1Garay-sevilla ME,Nava LE,Malacara JM,et al.Advanced glyeosylation and products (AGEs)、 insulin-like growth factor-1 and IGF-binding protein-3(IGFBP-3) in patients with type 2 diabetes mellitus[ J ].Diabetes Metab Rev,2000,16(2):106
2Chiarelli F,Santilli F,Mohn A.Role of growth factors in the development of diabetic complications[ J ].Horm Res,2000,53(2):53
3Krsek M,Prazny M,Skrha J,et al.IGFBP-1 and its protective role in the pathogenesis of microangiopathy in the type 1 diabetes mellitus[ J ].Cas Lek Cesk,2001,140(8):234
4Lupla E,Elliot SI.IGF-1 decrease collgaen degradation in diabetic NOD mesangial cells:complications for diabetic nephropathy[ J ].Diabetes,1999,48(2):1638
5Janssen JA,Lamberts SW.Circulating IGF-1 and its protective role in the pathogenesis of diabetic angiopathy[ J ].Clin Endocrinol,2000,52(1):1
6Barkai K,Tombac ZA.Alternation in insulin-like growth factor binding protdn-1and sex hormone binding globulin Levels in type 1 diabetic adolescents with microalbuminuria[ J ].Diabetes Care,2001,24(3):605
7Verrotti A,Cieri F,Petitti MT,et al.Growth hormone and IGF-Ⅰ in diabetic children with and without microalbuminuria[ J ].Diabetes Nutr Metab,1999,12(4):271
4Janssen JA, Lamberts SW. Circulating IGF-1 and its protective role in the pathogenesis of diabetic angiopathy [ J ]. Clin Endocrinol, 2000,52(1) :1.
5Elias LL, Cunha HM, Morerira AC, et al. Different states of clini- cal control are associated with changes in IGF-1 and IGFBPs in chil- dren with congenital adrenal hyperplasia due to 21 -hydroxylase defi- ciency[ J]. Clin Endocrinol( Oxf), 2004,61 ( 1 ) :94-101.
6Chiarelli F, Santilli F, Mohn A. Role of growth factors in the devel- opment of diabetic complications[ J ]. Horm Res, 2000,53 (2) :53.
